13F
← All fund report cards

BAILARD, INC.

13F equity value
$4.4B
Positions
736
Top 10 concentration
30.0%
Quarters / total new picks
32 / 2,316
13F equity value over time
$0M$2B$5B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +2.7% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 56.2% of quarters (excess t = 0.08, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+0.1%
t-stat
0.08
Quarterly win rate
56%
Annualized excess
-0.7%
$1 → follow vs universe
$1.99 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.00320180630: follow 0.90320180930: follow 0.93720181231: follow 0.93720190331: follow 0.86920190630: follow 0.94320190930: follow 0.99620191231: follow 0.70520200331: follow 0.85420200630: follow 0.91320200930: follow 1.13420201231: follow 1.31820210331: follow 1.35720210630: follow 1.51020210930: follow 1.35920211231: follow 1.16020220331: follow 1.22720220630: follow 1.15820220930: follow 1.21220221231: follow 1.11620230331: follow 1.24520230630: follow 1.24020230930: follow 1.36120231231: follow 1.43720240331: follow 1.48120240630: follow 1.60620240930: follow 1.60220241231: follow 1.49920250331: follow 1.58720250630: follow 1.65520250930: follow 1.92220251231: follow 1.987 0.65 1.45 2.25 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 736 · 2026 Q1

Ticker Value Weight QoQ
AAPL $208M
4.8%
HOLD
NVDA $157M
3.6%
HOLD
MSFT $156M
3.6%
HOLD
SPY $131M
3.0%
HOLD
GOOGL $127M
2.9%
TRIM
GLD $127M
2.9%
TRIM
EFA $124M
2.9%
HOLD
GILD $102M
2.3%
HOLD
BIL $93M
2.1%
ADD
VGT $79M
1.8%
HOLD
JMTG $74M
1.7%
HOLD
IEFA $73M
1.7%
ADD
CMF $70M
1.6%
TRIM
VTI $64M
1.5%
HOLD
AMZN $55M
1.3%
ADD
VBR $55M
1.3%
HOLD
GOVT $54M
1.2%
ADD
V $46M
1.1%
HOLD
IVV $45M
1.0%
HOLD
JPM $44M
1.0%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.